FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 9 analysts with an average price target of $14.93. This is a potential upside of $5.29 (54.88%) from yesterday's end of day stock price of $9.64.

Amicus Therapeutics's activity chart (see below) currently has 97 price targets and 82 ratings on display. The stock rating distribution of FOLD is 15.79% HOLD and 84.21% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.75% with an average time for these price targets to be met of 403.43 days.

Highest price target for FOLD is $21, Lowest price target is $12, average price target is $14.93.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 15-Jan-2025.

Currently out of the existing stock ratings of FOLD, 3 are a HOLD (15.79%), 16 are a BUY (84.21%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$21

$11.35 (117.62%)

$21

26 days ago
(15-Jan-2025)

0/7 (0%)

$11.7 (125.81%)

Buy

$12

$2.35 (24.35%)

$25

1 months 28 days ago
(13-Dec-2024)

6/8 (75%)

$2.62 (27.93%)

315

Buy

$17

$7.35 (76.17%)

$16

2 months 29 days ago
(12-Nov-2024)

6/15 (40%)

$6.47 (61.44%)

454

Buy

$15

$5.35 (55.44%)

$13

3 months 24 days ago
(17-Oct-2024)

2/8 (25%)

$3.03 (25.31%)

578

Buy

$18

$8.35 (86.53%)

$16

5 months 4 days ago
(06-Sep-2024)

2/5 (40%)

$6.31 (53.98%)

371

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 403.43 days on average for the stock forecasts to be realized with a an average price target met ratio 53.75

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Elemer Piros works at BENCHMARK and has 6 price targets and 6 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Kristen Kluska with highest potential upside - $11.35

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Gil Blum with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?